2nd Quarter - Report

MCKENNA, LONG & ALDRIDGE for ALLERGAN

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$30,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 19, 2008 $30,000 Replaced
2nd Quarter - Amendment Feb 3, 2009 $50,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act of 2008, S.3127

LobbyistCovered position, as disclosed
JOHN MICHAEL CLERICI —
JENNIFER HANNESSCHLAGER —

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE; White House Office; Health & Human Services, Dept of (HHS)

Bills named: S. 3127 (110th)

Health Issues HCR

public health issues impacting pharmaceuticals; Select Agent Program and Biosafety Improvement Act of 2008, S.3127

LobbyistCovered position, as disclosed
JOHN MICHAEL CLERICI —
JENNIFER HANNESSCHLAGER —

Contacted: Defense, Dept of (DOD); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 3127 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.